Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Fianlimab + Cemiplimab for Melanoma
Recruiting1 awardPhase 3
Miami, Florida
This trial is testing two new drugs, fianlimab and cemiplimab, to treat melanoma skin cancer. It examines their effectiveness and how they work in both teenagers and adults. The drugs help the immune system fight cancer cells.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service